28 December 2025
No journal updates published yet
The public CMB journal page currently does not list published news items.
Read More

In collaboration with
Samarkand State Medical University
Clinical & Molecular Biomedicine (CMB) is an international, peer-reviewed, open-access journal for research that connects molecular discoveries with clinically meaningful applications. The journal publishes translational biomedical studies across molecular and cellular biology, clinical biochemistry, genomics, proteomics, metabolomics, microbiome research, oncology, neurobiology, biomarker discovery, drug discovery, gene and cell therapy, precision medicine, and immunology. CMB welcomes experimental, computational, and clinical work that improves understanding of disease mechanisms and supports better diagnosis, treatment, and patient care.
Shama Khan
Sarfraz Ahmed | Lalita Thangwal | Kim Ji Hoe
Barka Basharat | Nushrat Jahan | Mohammad Asim Azhar
Shanza Rehman | Sana Kauser | Syed Suhail Andrabi | Nida Mubin
Khuzin Dinislam | Minhal Abidi | Pratibha Prasad

All CMB articles are published in a fully open-access format so research is immediately and freely available to readers worldwide. Articles are published under the Creative Commons Attribution (CC BY) license, allowing sharing and reuse with proper attribution.
Review the guide for authors.
CMB does not currently require an article processing charge. According to the journal documents provided, authors can publish in the journal without APC payment.
Every submission is first screened by the editors and, if suitable, is typically sent to at least two independent reviewers for single anonymized peer review before a final editorial decision is made.
© 2026 Clinical & Molecular Biomedicine. All rights reserved.
© 2026 EditoryPress. All rights reserved.